Literature DB >> 10075963

Immunoreactive pancreatic Reg protein in sera from cystic fibrosis patients with and without pancreatic insufficiency.

J Carrère1, O Guy-Crotte, E Gaia, C Figarella.   

Abstract

BACKGROUND: The biological function of the Reg protein, a non-enzymic protein produced in fairly large amounts by pancreatic acinar cells, remains elusive. Its susceptibility to proteolysis leading to precipitation of the proteolysis product at neutral pH suggests that it could contribute to the protein plugging observed in cystic fibrosis (CF). AIMS: To study its behaviour in the serum of CF patients with or without pancreatic insufficiency and to compare it with that of other pancreatic secretory proteins. PATIENTS: 170 patients (93 with CF, 55 controls, and 22 with chronic pancreatitis) were studied.
METHODS: Reg protein was measured using a specific enzyme immunoassay and its molecular form in CF sera was characterised by gel filtration. Molecular gene expression was investigated by dot-blot hybridisation.
RESULTS: Reg protein was present in all CF sera studied from patients with or without pancreatic insufficiency, and in all cases the level was significantly higher than in controls. Its chromatographic behaviour in CF sera was identical with that of the protein present in normal serum. No correlation was found between the levels of Reg protein and trypsin(ogen) (or lipase) in CF, nor in control sera or normal pancreatic juice. Molecular gene expression of the corresponding proteins investigated in pancreatic tissues showed an absence of correlation between the mRNA levels.
CONCLUSIONS: Reg protein may not be a secretory exocrine protein like the digestive enzymes but rather a hormone-like secretory substance with an endocrine or paracrine function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075963      PMCID: PMC1727456          DOI: 10.1136/gut.44.4.545

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  Dried-blood spot screening for cystic fibrosis in the newborn.

Authors:  J R Crossley; R B Elliott; P A Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

2.  Isolation, characterization, and distribution of an unusual pancreatic human secretory protein.

Authors:  J Gross; R I Carlson; A W Brauer; M N Margolies; A L Warshaw; J R Wands
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

3.  Proteolysis of human trypsinogen 1. Pathogenic implication in chronic pancreatitis.

Authors:  C Figarella; M Amouric; O Guy-Crotte
Journal:  Biochem Biophys Res Commun       Date:  1984-01-13       Impact factor: 3.575

4.  Endocrine pancreas in cystic fibrosis: an immunohistochemical study.

Authors:  A Iannucci; K Mukai; D Johnson; B Burke
Journal:  Hum Pathol       Date:  1984-03       Impact factor: 3.466

5.  The immunohistochemical evaluation of PSP/reg-protein in normal and diseased human pancreatic tissues.

Authors:  Y Satomura; N Sawabu; H Ohta; H Watanabe; O Yamakawa; Y Motoo; T Okai; D Toya; H Makino; H Okamoto
Journal:  Int J Pancreatol       Date:  1993-02

6.  Characterization and N-terminal sequence of a degradation product of 14,000 molecular weight isolated from human pancreatic juice.

Authors:  O Guy-Crotte; M Amouric; C Figarella
Journal:  Biochem Biophys Res Commun       Date:  1984-12-14       Impact factor: 3.575

7.  Pancreatic proteins in normal state and pancreatic diseases in pancreatic juice and blood.

Authors:  C Figarella; M Amouric; J Carrère; B Miszczuk-Jamska; O Guy-Crotte
Journal:  Ric Clin Lab       Date:  1984 Jul-Sep

8.  Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.

Authors:  P R Durie; G G Forstner; K J Gaskin; D J Moore; G J Cleghorn; S S Wong; M L Corey
Journal:  Pediatr Res       Date:  1986-03       Impact factor: 3.756

9.  Non-competitive enzyme immunoassay of human trypsin 1.

Authors:  J Carrere; R Grataroli; J Marfin; B Ferrua; J P Thouvenot; C Figarella
Journal:  J Immunol Methods       Date:  1983-05-27       Impact factor: 2.303

10.  Protein content of precipitates present in pancreatic juice of alcoholic subjects and patients with chronic calcifying pancreatitis.

Authors:  O Guy; G Robles-Diaz; Z Adrich; J Sahel; H Sarles
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

View more
  5 in total

1.  Comprehensive screening for reg1alpha gene rules out association with tropical calcific pancreatitis.

Authors:  Swapna Mahurkar; Seema Bhaskar; D Nageshwar Reddy; G Venkat Rao; Giriraj Ratan Chandak
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

2.  Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D.

Authors:  Jordana E Hoppe; Brandie D Wagner; J Kirk Harris; Steven M Rowe; Sonya L Heltshe; Emily M DeBoer; Scott D Sagel
Journal:  J Cyst Fibros       Date:  2022-04-16       Impact factor: 5.527

3.  Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.

Authors:  Alexander Fleming; Lawrence Rosenberg
Journal:  J Diabetes Sci Technol       Date:  2007-03

4.  Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.

Authors:  Qing Li; Hao Wang; George Zogopoulos; Qin Shao; Kun Dong; Fudong Lv; Karam Nwilati; Xian-Yong Gui; Adeline Cuggia; Jun-Li Liu; Zu-Hua Gao
Journal:  Oncotarget       Date:  2016-11-22

5.  Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population.

Authors:  Haijie Xing; Xiangdong Chen; Hongxia Sun; Yaofeng Han; Lanshu Ding; Xiaoxia Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-20       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.